Celularity Stock Analysis

Celularity Stock Analysis Notes

The company recorded a loss per share of 0.87. Celularity had not issued any dividends in recent years. Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey. Celularity Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 225 people. For more info on Celularity please contact Robert MD at 908 768 2170 or go to https://www.celularity.com.

Celularity Investment Alerts

Celularity Profitablity

The company has Profit Margin (PM) of (2.64) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.84) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.84.

Management Efficiency

The company has return on total asset (ROA) of (0.1463) % which means that it has lost $0.1463 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.5423) %, meaning that it generated substantial loss on money invested by shareholders. Celularity's management efficiency ratios could be used to measure how well Celularity manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to -1.49 in 2024. Return On Capital Employed is likely to climb to -2.39 in 2024. At this time, Celularity's Non Currrent Assets Other are fairly stable compared to the past year. Total Current Assets is likely to climb to about 30 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 117.9 M in 2024.

Technical Drivers

As of the 23rd of November, Celularity shows the Downside Deviation of 19.34, mean deviation of 13.7, and Risk Adjusted Performance of 0.0904. Celularity technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Celularity downside deviation, treynor ratio, as well as the relationship between the Treynor Ratio and expected short fall to decide if Celularity is priced correctly, providing market reflects its regular price of 0.022 per share. As Celularity appears to be a penny stock we also recommend to validate its total risk alpha numbers.

Celularity Price Movement Analysis

Celularity Insider Trading Activities

Celularity Predictive Daily Indicators

Celularity Forecast Models

Celularity's time-series forecasting models are one of many Celularity's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Celularity's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Celularity prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Celularity shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Celularity. By using and applying Celularity Stock analysis, traders can create a robust methodology for identifying Celularity entry and exit points for their positions.

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.